Open Access Journal of Clinical Trials

Scope & Guideline

Empowering Research Through Open Access Innovation.

Introduction

Welcome to your portal for understanding Open Access Journal of Clinical Trials, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1179-1519
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationOPEN ACCESS J CLIN T / Open Access J. Clin. Trials
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The Open Access Journal of Clinical Trials focuses on disseminating innovative clinical research findings, methodologies, and best practices across various health disciplines. Its core areas emphasize the importance of rigorous trial designs, participant engagement, and the evaluation of health interventions.
  1. Clinical Trial Methodologies:
    The journal emphasizes the development and evaluation of various clinical trial designs, including randomized controlled trials, pilot studies, and pragmatic trials, ensuring robust methodological standards.
  2. Patient-Centric Research:
    Research focused on participant compliance, satisfaction, and engagement in clinical trials highlights the importance of patient perspectives in the design and implementation of health interventions.
  3. Interventions for Vulnerable Populations:
    A consistent focus on clinical trials targeting specific age groups or vulnerable populations, such as older adults, individuals with chronic conditions, and patients with mental health issues, showcases the journal's commitment to addressing health disparities.
  4. Translational Research:
    The journal publishes findings that bridge the gap between laboratory research and clinical practice, promoting the application of scientific discoveries in real-world settings.
  5. Holistic and Multidomain Interventions:
    Research on multifaceted interventions, particularly for chronic conditions and mental health, emphasizes the complexity of health challenges and the need for comprehensive treatment approaches.
Recent publications reflect an evolving focus within the journal, highlighting emerging themes that resonate with contemporary health challenges and research priorities.
  1. COVID-19 Related Research:
    The journal has seen a significant increase in studies related to COVID-19, including vaccine efficacy and treatment protocols, reflecting the ongoing global health crisis and the need for timely research.
  2. Mental Health Interventions:
    There is a growing emphasis on mental health, particularly interventions designed for specific populations, such as older adults with HIV, indicating a recognition of the increasing importance of mental well-being in overall health outcomes.
  3. Home-Based Healthcare Interventions:
    Research focused on home-based interventions, such as home blood pressure monitoring, is trending, showcasing a shift towards patient-centered care that empowers individuals to manage their health in familiar settings.
  4. Social Support Mechanisms:
    Emerging themes around social support interventions for chronic disease management, like diabetes, highlight the importance of community and social networks in improving health outcomes.

Declining or Waning

While the journal continues to evolve, certain themes have shown a decrease in prominence in recent publications. These waning scopes suggest shifting priorities within the clinical trial research landscape.
  1. Traditional Medicine Trials:
    Although the journal has recently published work on traditional Chinese medicine, the broader focus on alternative and complementary therapies appears to be declining, possibly due to a growing emphasis on evidence-based practices.
  2. Single-Dose Trials:
    The publication of single-dose trials has become less frequent, indicating a possible shift towards more comprehensive intervention studies that assess longer-term effects and multi-dose strategies.
  3. Niche Pharmaceutical Interventions:
    Research on specific pharmaceutical alternatives, such as the Gabapentinoid for cocaine consumption problems, has decreased, suggesting a trend towards broader health interventions rather than niche pharmaceutical solutions.

Similar Journals

PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE

Pioneering Research in Psychotherapy and Psychosomatics
Publisher: GEORG THIEME VERLAG KGISSN: 0937-2032Frequency: 12 issues/year

PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed journal focused on the interdisciplinary fields of psychotherapy, psychosomatics, and medical psychology. Since its inception in 1980, this journal has emerged as a significant platform for researchers and professionals to disseminate findings that bridge psychological theory and clinical practice, significantly contributing to the advancement of applied psychology, clinical psychology, and psychiatry. With an ongoing convergence of research until 2024, the journal maintains a vital role in its field, holding a Q3 ranking in multiple categories as of 2023, reflecting its relevance and quality within the academic community. Though not an open-access journal, it provides crucial insights that influence both scholarly discourse and clinical methodologies, making it an essential resource for anyone engaged in understanding the complexities of mental health and psychosomatic conditions.

Global Journal of Medical Pharmaceutical and Biomedical Update

Bridging Gaps in Pharmaceutical and Biomedical Research
Publisher: SCIENTIFIC SCHOLAR LLCISSN: Frequency: 1 issue/year

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

NEW ENGLAND JOURNAL OF MEDICINE

Navigating the Future of Medicine with Authority
Publisher: MASSACHUSETTS MEDICAL SOCISSN: 0028-4793Frequency: 52 issues/year

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Advancing medical knowledge, one study at a time.
Publisher: ELSEVIER SCIENCE INCISSN: 0002-9629Frequency: 12 issues/year

The American Journal of the Medical Sciences, published by Elsevier Science Inc, has been a cornerstone in the field of medicine since its inception in 1945. With ISSN 0002-9629 and E-ISSN 1538-2990, this esteemed journal provides a comprehensive forum for the dissemination of cutting-edge research and clinical advancements across various medical disciplines. It currently holds a distinguished Q2 ranking in the field of Medicine (miscellaneous) and ranks #118 out of 636 in General Medicine on Scopus, reflecting its significant impact with an 81st percentile rating. While it operates under a traditional publishing model, which ensures rigorous peer-review processes, its commitment to disseminating vital medical knowledge remains paramount. Based in the United States at STE 800, 230 Park Ave, New York, NY 10169, the journal aims to bridge the gap between research and practice, making it an invaluable resource for researchers, healthcare professionals, and students dedicated to advancing medical science and improving patient care.

PHARMACEUTICAL STATISTICS

Transforming Data into Knowledge in Pharmaceutical Sciences
Publisher: WILEYISSN: 1539-1604Frequency: 6 issues/year

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Integrative Medicine Research

Advancing the Future of Complementary Care
Publisher: ELSEVIERISSN: 2213-4220Frequency: 4 issues/year

Integrative Medicine Research, published by Elsevier, is a premier journal dedicated to advancing the field of Complementary and Alternative Medicine. With an impact factor that reflects its esteemed position—ranking 15th out of 105 journals in its category as of 2023 and placing in the 86th percentile—this journal serves as a pivotal platform for researchers, professionals, and students alike. Since its transition to an Open Access model in 2012, it has enhanced the dissemination of critical research, fostering collaboration and application of integrative approaches to health and wellness. The journal encompasses a wide array of topics within its scope, encouraging submissions that contribute to the evidence base of integrative practices and their effects on health outcomes. As a quarterly publication based in South Korea, it emphasizes the importance of global perspectives in research, thereby inspiring innovation in complementary healthcare practices.

Journal of the Chinese Medical Association

Elevating Standards in Medical Research and Practice
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1726-4901Frequency: 12 issues/year

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Annals of Indian Academy of Neurology

Connecting Researchers, Practitioners, and Students in Neurology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Contemporary Clinical Trials

Exploring New Frontiers in Clinical Trials
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7144Frequency: 6 issues/year

Contemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.

Archives of Medical Science

Connecting experts to elevate medical practices.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1734-1922Frequency: 6 issues/year

Archives of Medical Science is a prestigious open-access journal dedicated to the dissemination of high-quality research in the field of medicine, encompassing a broad spectrum of medical sciences. Published by TERMEDIA PUBLISHING HOUSE LTD and operating from Poland, this journal has established itself as a vital platform for innovative findings and insightful reviews since its inception in 2005. With an impressive impact factor and ranked Q2 in the medicine (miscellaneous) category, it has garnered recognition within the global scientific community, currently placed in the 84th percentile according to Scopus rankings. The journal covers a range of topics that reflect current trends and advancements in medicine, offering valuable resources to researchers, professionals, and students. Its commitment to open access ensures that research is readily available to a wider audience, fostering collaboration and knowledge sharing. With contributions from leading experts, Archives of Medical Science is poised to continue influencing medical practices and policies well into the future.